Aura Biosciences Inc (AURA) USD0.00001

Sell:$8.18Buy:$8.26$0.20 (2.32%)

Prices delayed by at least 15 minutes
Sell:$8.18
Buy:$8.26
Change:$0.20 (2.32%)
Prices delayed by at least 15 minutes
Sell:$8.18
Buy:$8.26
Change:$0.20 (2.32%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
18 November 2024
Janet Jill HopkinsOther Level A
Sell
Tax related
11,822$9.36$110,663.38151,693
29 October 2024
Elisabet (Eli) De Los PinosChairman/CEO
Sell
Tax related
9,200$10.74$98,787.76320,647
29 October 2024
Amy ElazzouziVice President
Sell
Tax related
553$10.74$5,938.3939,443
18 October 2024
Elisabet (Eli) De Los PinosChairman/CEO
Sell
Option/Award related
24,992$12.04$300,838.70329,847
18 October 2024
Julie B FederCFO
Sell
Option/Award related
25,131$12.03$302,361.11134,276
16 October 2024
Mark PlavsicChief Level Officer
Sell
Tax related
7,383$9.85$72,722.55121,132
23 January 2024
Elisabet (Eli) De Los PinosChairman/CEO
Sell
Tax related
15,853$7.64$121,140.70161,438
23 January 2024
Julie B FederCFO
Sell
Tax related
6,609$7.64$50,521.1862,991

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
18 October 2024
Julie B FederCFO
Sell
Option/Award related
25,131$12.03$302,361.11134,276
18 October 2024
Elisabet (Eli) De Los PinosChairman/CEO
Sell
Option/Award related
24,992$12.04$300,838.70329,847
23 January 2024
Elisabet (Eli) De Los PinosChairman/CEO
Sell
Tax related
15,853$7.64$121,140.70161,438
18 November 2024
Janet Jill HopkinsOther Level A
Sell
Tax related
11,822$9.36$110,663.38151,693
29 October 2024
Elisabet (Eli) De Los PinosChairman/CEO
Sell
Tax related
9,200$10.74$98,787.76320,647

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.